sales@fnfresearch.comTel: +86 21 80360450 | USA: +1-347-989-3985

Search Market Research Report

Home / Biotechnology / Oligonucleotide

Oligonucleotide Market By Offering (Equipment, Reagents & Consumables, and Synthesized Oligonucleotides), By Application (Research, Therapeutics, and Diagnostics), and By End-User (Academic Research Institutes, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2027

  • Publish On: Nov-2019
  • Total Pages: 110
  • Report Code: FAF-151
  • Base Year: 2018
  • Format:

Industry Insights

The report covers a forecast and an analysis of the oligonucleotide market on a global and regional level. The study provides historical data from 2013 to 2018 and a forecast from 2019 to 2027 based on revenue (USD Million). The study includes drivers and restraints of the oligonucleotide market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the oligonucleotide market on a global level.

In order to give the users of this report a comprehensive view of the oligonucleotide market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the oligonucleotide market by segmenting it based on type, connector type, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2027. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

The most significant growth factor driving the oligonucleotide market is the strong pipeline of antisense oligonucleotides and increased focus on a large number of product approvals and commercialization. Moreover, significant advancements witnessed in the field of antisense oligonucleotides at the therapeutic or clinical level is further contributing to the oligonucleotide market development on a global scale. The antisense field is gaining momentum and is set to offer promising growth opportunities with a strong pipeline of 135 oligonucleotides in various stages of clinical trials. Even when the market performance of antisense oligonucleotides is unpredictable as like other industry segments, the future looks highly promising. This is another major factor fuelling the oligonucleotide market globally.

By offering, the market is categorized into synthesized oligonucleotides (product and services), equipment, and reagents and consumables. Based on application, the market is sectored into therapeutics (RNAi, immunotherapy applications, nucleic acid aptamers, and antisense oligonucleotides), research (polymerase chain reaction, next-generation sequencing, qPCR, and others), and diagnostics. The end-user segment includes pharmaceutical and biotechnology companies, diagnostic laboratories, academic research institutes, and others.

Key players operating in the oligonucleotide market are BioTechnologies, Biosearch Technologies, Eurofins Genomics, Bioneer Corporation, Dalton Pharma Services, BianoScience, Bio-Synthesis, GE, Microsynth, ATDBio, BioSpring, Creative Biogene, GeneDesign, GenScript, IBA, Integrated DNA Technologies, Kaneka Eurogentec, Merck, Syngene, Thermo Fisher Scientific, TriLink, and Twist Bioscience, among others.

Global Oligonucleotide : Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Key Features of Oligonucleotide Report:

  • Oligonucleotide structure: Overview, industry life cycle analysis, supply chain analysis
  • Oligonucleotide : Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
  • Oligonucleotide size, trend, and forecast analysis
  • Oligonucleotide segments’ trend and forecast
  • Oligonucleotide ’s competitive landscapes: Market share, Product portfolio, New product launches, etc.
  • Oligonucleotide attractiveness and associated growth opportunities
  • Emerging trends in the Oligonucleotide .
  • Strategic growth opportunities for the existing and new players
  • Key success factors

Benefits of Buying from Facts & Factors:

  • Our proven methodologies and systematic analysis help in making confident business and strategic decisions.
  • A market study that conducts at Facts & Factors Market Research can save significant cost and time, and can help prevent making costly mistakes.

Table of Content

  • Chapter 1. Executive Summary 23
  • Chapter 2. Oligonucleotide market – Offering Analysis 25
    • 2.1. Global Oligonucleotide Market – Offering Overview 25
    • 2.2. Global Oligonucleotide Market Share, by Offering, 2018 & 2025 (USD Million) 25
    • 2.3. Equipment 27
      • 2.3.1. Global Equipment Oligonucleotide Market, 2015-2025 (USD Million) 27
    • 2.4. Reagents & Consumables 28
      • 2.4.1. Global Reagents & Consumables Oligonucleotide Market, 2015-2025 (USD Million) 28
    • 2.5. Synthesized Oligonucleotides 29
      • 2.5.1. Global Synthesized Oligonucleotides Oligonucleotide Market, 2015-2025 (USD Million) 29
  • Chapter 3. Oligonucleotide market – Application Analysis 29
    • 3.1. Global Oligonucleotide Market – Application Overview 29
    • 3.2. Global Oligonucleotide Market Share, by Application, 2018 & 2025 (USD Million) 30
    • 3.3. Research 31
      • 3.3.1. Global Research Oligonucleotide Market, 2015-2025 (USD Million) 31
    • 3.4. Therapeutics 32
      • 3.4.1. Global Therapeutics Oligonucleotide Market, 2015-2025 (USD Million) 32
    • 3.5. Diagnostics 33
      • 3.5.1. Global Diagnostics Oligonucleotide Market, 2015-2025 (USD Million) 33
  • Chapter 4. Oligonucleotide market – End-User Analysis 33
    • 4.1. Global Oligonucleotide Market – End-User Overview 33
    • 4.2. Global Oligonucleotide Market Share, by End-User, 2018 & 2025 (USD Million) 34
    • 4.3. Academic Research Institutes 35
      • 4.3.1. Global Academic Research Institutes Oligonucleotide Market, 2015-2025 (USD Million) 35
    • 4.4. Diagnostic Laboratories 36
      • 4.4.1. Global Diagnostic Laboratories Oligonucleotide Market, 2015-2025 (USD Million) 36
    • 4.5. Pharmaceutical & Biotechnology Companies 37
      • 4.5.1. Global Pharmaceutical & Biotechnology Companies Oligonucleotide Market, 2015-2025 (USD Million) 37
    • 4.6. Others 38
      • 4.6.1. Global Others Oligonucleotide Market, 2015-2025 (USD Million) 38
  • Chapter 5. Oligonucleotide market – Regional Analysis 39
    • 5.1. Global Oligonucleotide Market Regional Overview 39
    • 5.2. Global Oligonucleotide Market Share, by Region, 2018 & 2025 (Value) 39
    • 5.3. North America 41
      • 5.3.1. North America Oligonucleotide Market size and forecast, 2015-2025 41
      • 5.3.2. North America Oligonucleotide Market, by Country, 2018 & 2025 (USD Million) 41
      • 5.3.3. North America Oligonucleotide Market, by Offering, 2015-2025 43
        • 5.3.3.1. North America Oligonucleotide Market, by Offering, 2015-2025 (USD Million) 43
      • 5.3.4. North America Oligonucleotide Market, by Application, 2015-2025 44
        • 5.3.4.1. North America Oligonucleotide Market, by Application, 2015-2025 (USD Million) 44
      • 5.3.5. North America Oligonucleotide Market, by End-User, 2015-2025 45
        • 5.3.5.1. North America Oligonucleotide Market, by End-User, 2015-2025 (USD Million) 45
      • 5.3.6. U.S. 46
        • 5.3.6.1. U.S. Market size and forecast, 2015-2025 (USD Million) 46
      • 5.3.7. Canada 47
        • 5.3.7.1. Canada Market size and forecast, 2015-2025 (USD Million) 47
      • 5.3.8. Mexico 48
        • 5.3.8.1. Mexico Market size and forecast, 2015-2025 (USD Million) 48
    • 5.4. Europe 49
      • 5.4.1. Europe Oligonucleotide Market size and forecast, 2015-2025 49
      • 5.4.2. Europe Oligonucleotide Market, by Country, 2018 & 2025 (USD Million) 49
      • 5.4.3. Europe Oligonucleotide Market, by Offering, 2015-2025 51
        • 5.4.3.1. Europe Oligonucleotide Market, by Offering, 2015-2025 (USD Million) 51
      • 5.4.4. Europe Oligonucleotide Market, by Application, 2015-2025 52
        • 5.4.4.1. Europe Oligonucleotide Market, by Application, 2015-2025 (USD Million) 52
      • 5.4.5. Europe Oligonucleotide Market, by End-User, 2015-2025 53
        • 5.4.5.1. Europe Oligonucleotide Market, by End-User, 2015-2025 (USD Million) 53
      • 5.4.6. Germany 54
        • 5.4.6.1. Germany Market size and forecast, 2015-2025 (USD Million) 54
      • 5.4.7. France 55
        • 5.4.7.1. France Market size and forecast, 2015-2025 (USD Million) 55
      • 5.4.8. U.K. 56
        • 5.4.8.1. U.K. Market size and forecast, 2015-2025 (USD Million) 56
      • 5.4.9. Italy 57
        • 5.4.9.1. Italy Market size and forecast, 2015-2025 (USD Million) 57
      • 5.4.10. Spain 58
        • 5.4.10.1. Spain Market size and forecast, 2015-2025 (USD Million) 58
      • 5.4.11. Nordic Countries 59
        • 5.4.11.1. Nordic Countries Market size and forecast, 2015-2025 (USD Million) 59
      • 5.4.12. Benelux Union 60
        • 5.4.12.1. Benelux Union Market size and forecast, 2015-2025 (USD Million) 60
      • 5.4.13. Rest of Europe 61
        • 5.4.13.1. Rest of Europe Market size and forecast, 2015-2025 (USD Million) 61
    • 5.5. Asia Pacific 62
      • 5.5.1. Asia Pacific Oligonucleotide Market size and forecast, 2015-2025 62
      • 5.5.2. Asia Pacific Oligonucleotide Market, by Country, 2018 & 2025 (USD Million) 62
      • 5.5.3. Asia Pacific Oligonucleotide Market, by Offering, 2015-2025 64
        • 5.5.3.1. Asia Pacific Oligonucleotide Market, by Offering, 2015-2025 (USD Million) 64
      • 5.5.4. Asia Pacific Oligonucleotide Market, by Application, 2015-2025 65
        • 5.5.4.1. Asia Pacific Oligonucleotide Market, by Application, 2015-2025 (USD Million) 65
      • 5.5.5. Asia Pacific Oligonucleotide Market, by End-User, 2015-2025 66
        • 5.5.5.1. Asia Pacific Oligonucleotide Market, by End-User, 2015-2025 (USD Million) 66
      • 5.5.6. China 67
        • 5.5.6.1. China Market size and forecast, 2015-2025 (USD Million) 67
      • 5.5.7. Japan 68
        • 5.5.7.1. Japan Market size and forecast, 2015-2025 (USD Million) 68
      • 5.5.8. India 69
        • 5.5.8.1. India Market size and forecast, 2015-2025 (USD Million) 69
      • 5.5.9. New Zealand 70
        • 5.5.9.1. New Zealand Market size and forecast, 2015-2025 (USD Million) 70
      • 5.5.10. Australia 71
        • 5.5.10.1. Australia Market size and forecast, 2015-2025 (USD Million) 71
      • 5.5.11. South  Korea 72
        • 5.5.11.1. South  Korea Market size and forecast, 2015-2025 (USD Million) 72
      • 5.5.12. South-East Asia 73
        • 5.5.12.1. South-East Asia Market size and forecast, 2015-2025 (USD Million) 73
      • 5.5.13. Rest of Asia Pacific 74
        • 5.5.13.1. Rest of Asia Pacific Market size and forecast, 2015-2025 (USD Million) 74
    • 5.6. Latin America 75
      • 5.6.1. Latin America Oligonucleotide Market size and forecast, 2015-2025 75
      • 5.6.2. Latin America Oligonucleotide Market, by Country, 2018 & 2025 (USD Million) 75
      • 5.6.3. Latin America Oligonucleotide Market, by Offering, 2015-2025 77
        • 5.6.3.1. Latin America Oligonucleotide Market, by Offering, 2015-2025 (USD Million) 77
      • 5.6.4. Latin America Oligonucleotide Market, by Application, 2015-2025 78
        • 5.6.4.1. Latin America Oligonucleotide Market, by Application, 2015-2025 (USD Million) 78
      • 5.6.5. Latin America Oligonucleotide Market, by End-User, 2015-2025 79
        • 5.6.5.1. Latin America Oligonucleotide Market, by End-User, 2015-2025 (USD Million) 79
      • 5.6.6. Brazil 80
        • 5.6.6.1. Brazil Market size and forecast, 2015-2025 (USD Million) 80
      • 5.6.7. Argentina 81
        • 5.6.7.1. Argentina Market size and forecast, 2015-2025 (USD Million) 81
      • 5.6.8. Rest of Latin America 82
        • 5.6.8.1. Rest of Latin America Market size and forecast, 2015-2025 (USD Million) 82
    • 5.7. The Middle-East and Africa 83
      • 5.7.1. The Middle-East and Africa Oligonucleotide Market size and forecast, 2015-2025 83
      • 5.7.2. The Middle-East and Africa Oligonucleotide Market, by Country, 2018 & 2025 (USD Million) 83
      • 5.7.3. The Middle-East and Africa Oligonucleotide Market, by Offering, 2015-2025 85
        • 5.7.3.1. The Middle-East and Africa Oligonucleotide Market, by Offering, 2015-2025 (USD Million) 85
      • 5.7.4. The Middle-East and Africa Oligonucleotide Market, by Application, 2015-2025 86
        • 5.7.4.1. The Middle-East and Africa Oligonucleotide Market, by Application, 2015-2025 (USD Million) 86
      • 5.7.5. The Middle-East and Africa Oligonucleotide Market, by End-User, 2015-2025 87
        • 5.7.5.1. The Middle-East and Africa Oligonucleotide Market, by End-User, 2015-2025 (USD Million) 87
      • 5.7.6. Saudi Arabia 88
        • 5.7.6.1. Saudi Arabia Market size and forecast, 2015-2025 (USD Million) 88
      • 5.7.7. UAE 89
        • 5.7.7.1. UAE Market size and forecast, 2015-2025 (USD Million) 89
      • 5.7.8. Egypt 90
        • 5.7.8.1. Egypt Market size and forecast, 2015-2025 (USD Million) 90
      • 5.7.9. Kuwait 91
        • 5.7.9.1. Kuwait Market size and forecast, 2015-2025 (USD Million) 91
      • 5.7.10. South Africa 92
        • 5.7.10.1. South Africa Market size and forecast, 2015-2025 (USD Million) 92
      • 5.7.11. Rest of Middle-East Africa 93
        • 5.7.11.1. Rest of Middle-East Africa Market size and forecast, 2015-2025 (USD Million) 93
  • Chapter 6. Oligonucleotide market – Competitive Landscape 94
    • 6.1. Competitor Market Share – Revenue 94
    • 6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players 96
    • 6.3. Strategic Development 97
      • 6.3.1. Acquisitions and Mergers 97
      • 6.3.2. New Products 97
      • 6.3.3. Research & Development Activities 97
  • Chapter 7. Company Profiles 98
    • 7.1. BioTechnologies 98
      • 7.1.1. Company Overview 98
      • 7.1.2. BioTechnologies Revenue and Gross Margin 98
      • 7.1.3. Product portfolio 99
      • 7.1.4. Recent initiatives 100
    • 7.2. Biosearch Technologies 100
      • 7.2.1. Company Overview 100
      • 7.2.2. Biosearch Technologies Revenue and Gross Margin 100
      • 7.2.3. Product portfolio 101
      • 7.2.4. Recent initiatives 102
    • 7.3. Eurofins Genomics 102
      • 7.3.1. Company Overview 102
      • 7.3.2. Eurofins Genomics Revenue and Gross Margin 102
      • 7.3.3. Product portfolio 103
      • 7.3.4. Recent initiatives 104
    • 7.4. Bioneer Corporation 104
      • 7.4.1. Company Overview 104
      • 7.4.2. Bioneer Corporation Revenue and Gross Margin 104
      • 7.4.3. Product portfolio 105
      • 7.4.4. Recent initiatives 106
    • 7.5. Dalton Pharma Services 106
      • 7.5.1. Company Overview 106
      • 7.5.2. Dalton Pharma Services Revenue and Gross Margin 106
      • 7.5.3. Product portfolio 107
      • 7.5.4. Recent initiatives 108
    • 7.6. BianoScience 108
      • 7.6.1. Company Overview 108
      • 7.6.2. BianoScience Revenue and Gross Margin 108
      • 7.6.3. Product portfolio 109
      • 7.6.4. Recent initiatives 110
    • 7.7. Bio-Synthesis 110
      • 7.7.1. Company Overview 110
      • 7.7.2. Bio-Synthesis Revenue and Gross Margin 110
      • 7.7.3. Product portfolio 111
      • 7.7.4. Recent initiatives 112
    • 7.8. GE 112
      • 7.8.1. Company Overview 112
      • 7.8.2. GE Revenue and Gross Margin 112
      • 7.8.3. Product portfolio 113
      • 7.8.4. Recent initiatives 114
    • 7.9. Microsynth 114
      • 7.9.1. Company Overview 114
      • 7.9.2. Microsynth Revenue and Gross Margin 114
      • 7.9.3. Product portfolio 115
      • 7.9.4. Recent initiatives 116
    • 7.10. ATDBio 116
      • 7.10.1. Company Overview 116
      • 7.10.2. ATDBio Revenue and Gross Margin 116
      • 7.10.3. Product portfolio 117
      • 7.10.4. Recent initiatives 118
    • 7.11. BioSpring 118
      • 7.11.1. Company Overview 118
      • 7.11.2. BioSpring Revenue and Gross Margin 118
      • 7.11.3. Product portfolio 119
      • 7.11.4. Recent initiatives 120
    • 7.12. Creative Biogene 120
      • 7.12.1. Company Overview 120
      • 7.12.2. Creative Biogene Revenue and Gross Margin 120
      • 7.12.3. Product portfolio 121
      • 7.12.4. Recent initiatives 122
    • 7.13. GeneDesign 122
      • 7.13.1. Company Overview 122
      • 7.13.2. GeneDesign Revenue and Gross Margin 122
      • 7.13.3. Product portfolio 123
      • 7.13.4. Recent initiatives 124
    • 7.14. GenScript 124
      • 7.14.1. Company Overview 124
      • 7.14.2. GenScript Revenue and Gross Margin 124
      • 7.14.3. Product portfolio 125
      • 7.14.4. Recent initiatives 126
    • 7.15. IBA 126
      • 7.15.1. Company Overview 126
      • 7.15.2. IBA Revenue and Gross Margin 126
      • 7.15.3. Product portfolio 127
      • 7.15.4. Recent initiatives 128
    • 7.16. Integrated DNA Technologies 128
      • 7.16.1. Company Overview 128
      • 7.16.2. Integrated DNA Technologies Revenue and Gross Margin 128
      • 7.16.3. Product portfolio 129
      • 7.16.4. Recent initiatives 130
    • 7.17. Kaneka Eurogentec 130
      • 7.17.1. Company Overview 130
      • 7.17.2. Kaneka Eurogentec Revenue and Gross Margin 130
      • 7.17.3. Product portfolio 131
      • 7.17.4. Recent initiatives 132
    • 7.18. Merck 132
      • 7.18.1. Company Overview 132
      • 7.18.2. Merck Revenue and Gross Margin 132
      • 7.18.3. Product portfolio 133
      • 7.18.4. Recent initiatives 134
    • 7.19. Syngene 134
      • 7.19.1. Company Overview 134
      • 7.19.2. Syngene Revenue and Gross Margin 134
      • 7.19.3. Product portfolio 135
      • 7.19.4. Recent initiatives 136
    • 7.20. Thermo Fisher Scientific 136
      • 7.20.1. Company Overview 136
      • 7.20.2. Thermo Fisher Scientific Revenue and Gross Margin 136
      • 7.20.3. Product portfolio 137
      • 7.20.4. Recent initiatives 138
    • 7.21. TriLink 138
      • 7.21.1. Company Overview 138
      • 7.21.2. TriLink Revenue and Gross Margin 138
      • 7.21.3. Product portfolio 139
      • 7.21.4. Recent initiatives 140
    • 7.22. Twist Bioscience 140
      • 7.22.1. Company Overview 140
      • 7.22.2. Twist Bioscience Revenue and Gross Margin 140
      • 7.22.3. Product portfolio 141
      • 7.22.4. Recent initiatives 142
  • Chapter 8. Oligonucleotide — Industry Analysis 143
    • 8.1. Oligonucleotide Market – Key Trends 143
      • 8.1.1. Market Drivers 144
      • 8.1.2. Market Restraints 144
      • 8.1.3. Market Opportunities 145
    • 8.2. Value Chain Analysis 146
    • 8.3. Technology Roadmap and Timeline 147
    • 8.4. Oligonucleotide Market – Attractiveness Analysis 148
      • 8.4.1. By Offering 148
      • 8.4.2. By Application 148
      • 8.4.3. By End-User 149
      • 8.4.4. By Region 151
  • Chapter 9. Marketing Strategy Analysis, Distributors 152
    • 9.1. Marketing Channel 152
    • 9.2. Direct Marketing 153
    • 9.3. Indirect Marketing 153
    • 9.4. Marketing Channel Development Trend 153
    • 9.5. Economic/Political Environmental Change 154
  • Chapter 10. Report Conclusion 155
  • Chapter 11. Research Approach & Methodology 156
    • 11.1. Report Description 156
    • 11.2. Research Scope 157
    • 11.3. Research Methodology 157
      • 11.3.1. Secondary Research 158
      • 11.3.2. Primary Research 159
      • 11.3.3. Models 160
        • 11.3.3.1. Company Share Analysis Model 160
        • 11.3.3.2. Revenue Based Modeling 161
        • 11.3.3.3. Research Limitations 161

List of Figures

FIG. 1 Global Oligonucleotide Market, 2015-2025 (USD Million) 24
FIG. 2 Global Oligonucleotide Market Share, by Offering, 2018 & 2025 (USD Million) 25
FIG. 3 Global Equipment Oligonucleotide Market, 2015-2025 (USD Million) 27
FIG. 4 Global Reagents & Consumables Oligonucleotide Market, 2015-2025 (USD Million) 28
FIG. 5 Global Synthesized Oligonucleotides Oligonucleotide Market, 2015-2025 (USD Million) 29
FIG. 6 Global Oligonucleotide Market Share, by Application, 2018 & 2025 (USD Million) 30
FIG. 7 Global Research Oligonucleotide Market, 2015-2025 (USD Million) 31
FIG. 8 Global Therapeutics Oligonucleotide Market, 2015-2025 (USD Million) 32
FIG. 9 Global Diagnostics Oligonucleotide Market, 2015-2025 (USD Million) 33
FIG. 10 Global Oligonucleotide Market Share, by End-User, 2018 & 2025 (USD Million) 34
FIG. 11 Global Academic Research Institutes Oligonucleotide Market, 2015-2025 (USD Million) 35
FIG. 12 Global Diagnostic Laboratories Oligonucleotide Market, 2015-2025 (USD Million) 36
FIG. 13 Global Pharmaceutical & Biotechnology Companies Oligonucleotide Market, 2015-2025 (USD Million) 37
FIG. 14 Global Others Oligonucleotide Market, 2015-2025 (USD Million) 38
FIG. 15 Global Oligonucleotide Market Share, by Region, 2018 & 2025 39
FIG. 16 North America Oligonucleotide Market, 2015-2025 41
FIG. 17 U.S. Oligonucleotide Market, 2015-2025 46
FIG. 18 Canada Oligonucleotide Market, 2015-2025 47
FIG. 19 Mexico Oligonucleotide Market, 2015-2025 48
FIG. 20 Europe Oligonucleotide Market, 2015-2025 49
FIG. 21 Germany Oligonucleotide Market, 2015-2025 54
FIG. 22 France Oligonucleotide Market, 2015-2025 55
FIG. 23 U.K. Oligonucleotide Market, 2015-2025 56
FIG. 24 Italy Oligonucleotide Market, 2015-2025 57
FIG. 25 Spain Oligonucleotide Market, 2015-2025 58
FIG. 26 Nordic Countries Oligonucleotide Market, 2015-2025 59
FIG. 27 Benelux Union Oligonucleotide Market, 2015-2025 60
FIG. 28 Rest of Europe Oligonucleotide Market, 2015-2025 61
FIG. 29 Asia Pacific Oligonucleotide Market, 2015-2025 62
FIG. 30 China Oligonucleotide Market, 2015-2025 67
FIG. 31 Japan Oligonucleotide Market, 2015-2025 68
FIG. 32 India Oligonucleotide Market, 2015-2025 69
FIG. 33 New Zealand Oligonucleotide Market, 2015-2025 70
FIG. 34 Australia Oligonucleotide Market, 2015-2025 71
FIG. 35 South  Korea Oligonucleotide Market, 2015-2025 72
FIG. 36 South-East Asia Oligonucleotide Market, 2015-2025 73
FIG. 37 Rest of Asia Pacific Oligonucleotide Market, 2015-2025 74
FIG. 38 Latin America Oligonucleotide Market, 2015-2025 75
FIG. 39 Brazil Oligonucleotide Market, 2015-2025 80
FIG. 40 Argentina Oligonucleotide Market, 2015-2025 81
FIG. 41 Rest of Latin America Oligonucleotide Market, 2015-2025 82
FIG. 42 The Middle-East and Africa Oligonucleotide Market, 2015-2025 83
FIG. 43 Saudi Arabia Oligonucleotide Market, 2015-2025 88
FIG. 44 UAE Oligonucleotide Market, 2015-2025 89
FIG. 45 Egypt Oligonucleotide Market, 2015-2025 90
FIG. 46 Kuwait Oligonucleotide Market, 2015-2025 91
FIG. 47 South Africa Oligonucleotide Market, 2015-2025 92
FIG. 48 Rest of Middle-East Africa Oligonucleotide Market, 2015-2025 93
FIG. 49 Competitor Market Share – Revenue 94
FIG. 50 BioTechnologies Revenue and Growth Rate 99
FIG. 51 BioTechnologies Market Share 99
FIG. 52 Biosearch Technologies Revenue and Growth Rate 101
FIG. 53 Biosearch Technologies Market Share 101
FIG. 54 Eurofins Genomics Revenue and Growth Rate 103
FIG. 55 Eurofins Genomics Market Share 103
FIG. 56 Bioneer Corporation Revenue and Growth Rate 105
FIG. 57 Bioneer Corporation Market Share 105
FIG. 58 Dalton Pharma Services Revenue and Growth Rate 107
FIG. 59 Dalton Pharma Services Market Share 107
FIG. 60 BianoScience Revenue and Growth Rate 109
FIG. 61 BianoScience Market Share 109
FIG. 62 Bio-Synthesis Revenue and Growth Rate 111
FIG. 63 Bio-Synthesis Market Share 111
FIG. 64 GE Revenue and Growth Rate 113
FIG. 65 GE Market Share 113
FIG. 66 Microsynth Revenue and Growth Rate 115
FIG. 67 Microsynth Market Share 115
FIG. 68 ATDBio Revenue and Growth Rate 117
FIG. 69 ATDBio Market Share 117
FIG. 70 BioSpring Revenue and Growth Rate 119
FIG. 71 BioSpring Market Share 119
FIG. 72 Creative Biogene Revenue and Growth Rate 121
FIG. 73 Creative Biogene Market Share 121
FIG. 74 GeneDesign Revenue and Growth Rate 123
FIG. 75 GeneDesign Market Share 123
FIG. 76 GenScript Revenue and Growth Rate 125
FIG. 77 GenScript Market Share 125
FIG. 78 IBA Revenue and Growth Rate 127
FIG. 79 IBA Market Share 127
FIG. 80 Integrated DNA Technologies Revenue and Growth Rate 129
FIG. 81 Integrated DNA Technologies Market Share 129
FIG. 82 Kaneka Eurogentec Revenue and Growth Rate 131
FIG. 83 Kaneka Eurogentec Market Share 131
FIG. 84 Merck Revenue and Growth Rate 133
FIG. 85 Merck Market Share 133
FIG. 86 Syngene Revenue and Growth Rate 135
FIG. 87 Syngene Market Share 135
FIG. 88 Thermo Fisher Scientific Revenue and Growth Rate 137
FIG. 89 Thermo Fisher Scientific Market Share 137
FIG. 90 TriLink Revenue and Growth Rate 139
FIG. 91 TriLink Market Share 139
FIG. 92 Twist Bioscience Revenue and Growth Rate 141
FIG. 93 Twist Bioscience Market Share 141
FIG. 94 Market Dynamics 143
FIG. 95 Global Oligonucleotide – Value Chain Analysis 146
FIG. 96 Technology Roadmap and Timeline 147
FIG. 97 Market Attractiveness Analysis – By Offering 148
FIG. 98 Market Attractiveness Analysis – By Application 149
FIG. 99 Market Attractiveness Analysis – By End-User 149
FIG. 100 Market Attractiveness Analysis – By Region 151
FIG. 101 Market Channel 152
FIG. 102 Marketing Channel Development Trend 153
FIG. 103 Growth in World Gross Product, 2008-2018 154

List of Tables

TABLE 1 Global Oligonucleotide Market, 2018 & 2025 (USD Million) 23
TABLE 2 Global Oligonucleotide market, by Offering, 2015-2025 (USD Million) 25
TABLE 3 Global Oligonucleotide market, by Application, 2015-2025 (USD Million) 30
TABLE 4 Global Oligonucleotide market, by End-User, 2015-2025 (USD Million) 34
TABLE 5 Global Oligonucleotide market, by Region, 2015-2025 (USD Million) 39
TABLE 6 North America Oligonucleotide Market, by Offering, 2015-2025 (USD Million) 43
TABLE 7 North America Oligonucleotide Market, by Application, 2015-2025 (USD Million) 44
TABLE 8 North America Oligonucleotide Market, by End-User, 2015-2025 (USD Million) 45
TABLE 9 Europe Oligonucleotide Market, by Offering, 2015-2025 (USD Million) 51
TABLE 10 Europe Oligonucleotide Market, by Application, 2015-2025 (USD Million) 52
TABLE 11 Europe Oligonucleotide Market, by End-User, 2015-2025 (USD Million) 53
TABLE 12 Asia Pacific Oligonucleotide Market, by Offering, 2015-2025 (USD Million) 64
TABLE 13 Asia Pacific Oligonucleotide Market, by Application, 2015-2025 (USD Million) 65
TABLE 14 Asia Pacific Oligonucleotide Market, by End-User, 2015-2025 (USD Million) 66
TABLE 15 Latin America Oligonucleotide Market, by Offering, 2015-2025 (USD Million) 77
TABLE 16 Latin America Oligonucleotide Market, by Application, 2015-2025 (USD Million) 78
TABLE 17 Latin America Oligonucleotide Market, by End-User, 2015-2025 (USD Million) 79
TABLE 18 The Middle-East and Africa Oligonucleotide Market, by Offering, 2015-2025 (USD Million) 85
TABLE 19 The Middle-East and Africa Oligonucleotide Market, by Application, 2015-2025 (USD Million) 86
TABLE 20 The Middle-East and Africa Oligonucleotide Market, by End-User, 2015-2025 (USD Million) 87
TABLE 21 Global Oligonucleotide Market - Company Revenue Analysis 2015-2018 (USD Million) 94
TABLE 22 Global Oligonucleotide Market - Company Revenue Share Analysis 2015-2018 (%) 96
TABLE 23 Acquisitions and Mergers 97
TABLE 24 New Product/Service Launch 97
TABLE 25 Research & Development Activities 97
TABLE 26 Market Drivers 144
TABLE 27 Market Restraints 144
TABLE 28 Market Opportunities 145

Industry Major Market Players

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2020 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions